Geneticure is a personalized medicine company with patented tests that control chronic diseases faster than trial/error, with less cost
Geneticure is a Mayo Clinic backed company that has created a patented cheek-swab test that can predict individual treatment response for high blood pressure medications and devices therapies.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 1, 2022 | Seed | $1.68M | — | — | — | Detail |
| Dec 31, 2019 | Seed | $1M | — | — | — | Detail |
| Apr 1, 2018 | Seed | $1.36M | 1 | — | — | Detail |
| Sep 1, 2017 | Seed | $850K | 1 |
|
— | Detail |
| Apr 5, 2017 | Seed | $200K | 1 | — | — | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Seed |
Fairview Health Services
|
Yes | Pre-seed |
Mayo Clinic Ventures
|
— | Seed |
|
|
— | Seed |